Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Heart Failure with Mid-range Ejection Fraction”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 0 results

Not applicableWithdrawnNCT04632160
What this trial is testing

Extended IASD Investigation: REDUCE LAP-HF IV

Who this might be right for
Heart Failure With Preserved Ejection FractionHeart Failure With Mid Range Ejection Fraction
Corvia Medical
Large-scale testing (Phase 3)Ended earlyNCT04727073
What this trial is testing

Spironolactone in the Treatment of Heart Failure

Who this might be right for
Heart Failure with Mid-range Ejection FractionHeart Failure with Preserved Ejection Fraction
Charite University, Berlin, Germany 743
Not applicableStudy completedNCT05795400
What this trial is testing

Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy

Who this might be right for
Heart Failure With Reduced Ejection FractionHeart Failure With Preserved Ejection FractionHeart Failure With Mid Range Ejection Fraction+1 more
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation 50